GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cyclacel Pharmaceuticals Inc (FRA:UXI) » Definitions » FCF Yield %

Cyclacel Pharmaceuticals (FRA:UXI) FCF Yield % : -611.22 (As of May. 06, 2024)


View and export this data going back to . Start your Free Trial

What is Cyclacel Pharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Cyclacel Pharmaceuticals's Trailing 12-Month Free Cash Flow is €-14.99 Mil, and Market Cap is €2.46 Mil. Therefore, Cyclacel Pharmaceuticals's FCF Yield % for today is -611.22%.

The historical rank and industry rank for Cyclacel Pharmaceuticals's FCF Yield % or its related term are showing as below:

FRA:UXI' s FCF Yield % Range Over the Past 10 Years
Min: -2334.01   Med: -96.42   Max: -17.69
Current: -611.22


During the past 13 years, the highest FCF Yield % of Cyclacel Pharmaceuticals was -17.69%. The lowest was -2334.01%. And the median was -96.42%.

FRA:UXI's FCF Yield % is ranked worse than
96.98% of 1555 companies
in the Biotechnology industry
Industry Median: -14.32 vs FRA:UXI: -611.22

Cyclacel Pharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was -12,803.57%.


Cyclacel Pharmaceuticals FCF Yield % Historical Data

The historical data trend for Cyclacel Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclacel Pharmaceuticals FCF Yield % Chart

Cyclacel Pharmaceuticals Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
FCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -100.58 -16.01 -49.68 -269.05 -428.58

Cyclacel Pharmaceuticals Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -267.02 -429.85 -78.69 -432.76 -415.80

Competitive Comparison of Cyclacel Pharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Cyclacel Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclacel Pharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cyclacel Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Cyclacel Pharmaceuticals's FCF Yield % falls into.



Cyclacel Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Cyclacel Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-14.781 / 3.44880473
=-428.58%

Cyclacel Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-3.585 * 4 / 3.44880473
=-415.80%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cyclacel Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cyclacel Pharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Cyclacel Pharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclacel Pharmaceuticals (FRA:UXI) Business Description

Traded in Other Exchanges
Address
200 Connell Drive, Suite 1500, Berkeley Heights, NJ, USA, 07922
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

Cyclacel Pharmaceuticals (FRA:UXI) Headlines

No Headlines